Navigation Links
InVitria Sponsors Cambridge Healthtech's Optimizing Cell Culture Development Conference
Date:9/4/2008

FORT COLLINS, Colo., Sept. 4 /PRNewswire/ -- InVitria (http://www.invitria.com), a leading global supplier of animal free products that enhance productivity, safety and time to market for companies in the biopharmaceutical, cell culture, life science research and diagnostics industry, announced its Sponsorship of Cambridge Healthtech Institute's 4th Annual "Optimizing Cell Culture Development" Conference on September 15-16 in Boston, Massachusetts. (http://www.healthtech.com/ocb/overview.aspx?c=562)

InVitria will be an exhibitor at the conference, which will feature notable speakers from research and development institutes and the biotech industry. The meeting sessions focus on cell line development, cell engineering, upstream processing and scale-up & manufacturing of products derived from cell culture.

"InVitria is very pleased to serve as one of the corporate sponsors for this event for the cell culture industry," said Scott Deeter, InVitria's president. "We feel this is a tremendous venue to build awareness of how InVitria's animal free products available for use in cell culture media help improve productivity, safety and time to market for our customers."

"InVitria's Cellastim and Lacromin not only replace bovine or human sources of albumin or transferrin, but they also provide improved productivity and better consistency," said Ray Tritch, InVitria's Account Manager - Eastern United States. "I am looking forward to sharing our successful results using these cell culture ingredients to optimize performance," Tritch said.

About InVitria (http://www.InVitria.com)

InVitria has developed animal free cell culture ingredients that enhance productivity, safety and time to market for companies in the biopharmaceutical, cell culture, life science research and diagnostics industry. InVitria's animal free product line includes:

-- Cellastim -- Cellastim is an albumin used to replace bovine albumin and human albumin as a cell culture ingredient and biopharmaceutical formulation excipient. Cellastim has been shown to improve mammalian cell culture productivity by up to 50% when compared with other forms of albumin. Cellastim also has been an effective component in stem cell media and primary cell media. (see http://www.Cellastim.com )

-- Lacromin -- Lacromin has been shown to replace bovine transferrin and human transferrin in cell culture media. In addition, Lacromin is a strong growth promotant as a cell culture ingredient in mammalian cell culture media. (see http://www.Lacromin.com )

-- Lysobac -- Lysobac is a bacterial cell lysis agent that is more efficient and more consistent compared to chicken lysozyme and provides higher protein yield compared with mechanical cell lysis. Lysobac is used in bacterial fermentation to improve recombinant protein yields. (see http://www.Lysobac.com )

For more information about the InVitria line of products, please e-mail info@invitria.com or call 1-800-916-8311.


'/>"/>
SOURCE InVitria
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. InVitria Further Strengthens Sales Team with Promotion of Brandy Sargent to Account Manager - Western United States
2. InVitria Expands Sales Team
3. InVitrias Animal Free Lacromin(TM) Provides a Cost-Effective Improvement Over Transferrin
4. TCN e-Systems Offers Trial Sponsors Solutions for Creating In-House Center of Excellence in Patient Recruitment
5. BioStorage Technologies Announces Platinum Sponsorship of Biorepositories 2008
6. Diplomat Specialty Pharmacy Sponsors National Managed Care Roundtable for Industry Executive Advisory Board
7. Baxa Announces Colorado BioScience Association Sponsorship
8. Varian Medical Systems Sponsors Special Broadcast of The Group Room(R), a Live Radio Talkshow About Cancer
9. SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market
10. Diageo Sponsors Medical Society of the State of New Yorks Physicians Training Program
11. New Fragment-based Drug Discovery Platform Announced Between IOTA Pharmaceuticals Ltd, Cambridge (UK), and Beactica AB, Uppsala (Sweden)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... New York, NY (PRWEB) , ... May 03, 2016 , ... ... Lenox Hill Hospital , for definitive prostate cancer treatment, patients traditionally had two main ... an appropriate treatment plan would be made. , New technology has enabled doctors ...
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... ... leading fertility clinics and IVF laboratories. A contingency of reproductive endocrinologists, including ... men and women experiencing infertility and to help them build families. , Ovation ...
(Date:5/2/2016)... 2016 Q BioMed Inc. (QBIO), ... Mannin Research Inc. will be attending the Association for ... from May 1-5, 2016 in Seattle Washington ... its vendors and research partners. The meeting provides organizations ... other collaborative opportunities for the MAN-01 program for treatment ...
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... ... with its clients in mind, the fresh look and added functionality give the ... “Recent years have seen a dynamic shift in agriculture – from precision farming ...
Breaking Biology Technology:
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration ... security to access and transact across channels. Using ...
Breaking Biology News(10 mins):